Research suggests that punicalagin, a compound found in pomegranates, may have antioxidant and antiviral properties, with one laboratory study finding it showed inhibitory activity against SARS-CoV-2 by interfering with the interaction between the virus's spike protein and the human ACE2 receptor. This evidence comes from a single in vitro study, meaning the findings were observed in a controlled laboratory setting rather than in humans, which is an important limitation to keep in mind when interpreting the results. The researchers themselves noted that clinical validation in human trials would be necessary before drawing broader conclusions about pomegranate compounds and infection risk. Overall, while the preliminary findings are of scientific interest, the current body of evidence is too limited to draw firm conclusions about pomegranate juice as a source of antioxidant or antiviral support in humans.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| The natural tannins oligomeric proanthocyanidins and punicalagin are potent i... | Other | 2023 | Neutral | 85 |